CIK 0001761612 · Non-accelerated filer<br>Smaller reporting company
BICYCLE THERAPEUTICS PLC
Sign in to watch- Ticker
- BCYC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 011441223261503
- Business address
- BLOCKS A & B, PORTWAY BUILDING, GRANTA PARK, GREAT ABINGTON, CAMBRIDGE, United Kingdom, CB21 6GS
- Former names
- BICYCLE THERAPEUTICS Ltd
- 4 Open-market sale Chief Executive Officer sold 55,362 shares at an average $33.30 ($1,843,436)
- 8-K Event Material agreement · Unregistered share sale
- 4 Open-market sale Chief Business Officer sold 271 shares at $32.00 ($8,672)
- 8-K Event Shareholder vote results
- DEFA14A Proxy Proxy Materials
- DEFA14A Proxy Proxy Materials
- 8-K Event Other events
- 424B5 Offering Prospectus
- 4 Open-market sale Chief Executive Officer sold 7,320 shares at an average $32.21 ($235,769)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market sale Chief Executive Officer sold 4,288 shares at an average $32.13 ($137,785)
- 4 Open-market sale Chief Executive Officer sold 58,919 shares at an average $30.86 ($1,817,988)
- DEF 14A Proxy Proxy Statement
- 4 Open-market sale Chief Executive Officer sold 25,247 shares at an average $31.13 ($785,873)
- PRE 14A Proxy Proxy Statement (Preliminary)
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Executive or director change
- 4 Open-market sale Director sold 24,838 shares at an average $31.71 ($787,588)
- 4 Open-market sale Director sold 162 shares at $31.07 ($5,033)
Page 24 of 33 · 660 filings